Literature DB >> 11324942

Comparative sequencing of the human CB1 cannabinoid receptor gene coding exon: no structural mutations in individuals exhibiting extreme responses to cannabis.

M R Hoehe1, T Rinn, C Flachmeier, P Heere, H J Kunert, B Timmermann, K Köpke, H Ehrenreich.   

Abstract

Rare but striking individual differences in responsiveness to cannabinoids have been observed that might involve mutations in the gene encoding the brain-expressed cannabinoid receptor. In a preliminary study, the human CB1 cannabinoid receptor coding region was comparatively sequenced in different groups of individuals: one group showed acute psychotic symptoms after cannabis intake, while another group did not develop any psychopathology after long-term heavy cannabis abuse. No evidence for structural mutations was obtained, which might provide some insight into the molecular basis of individually different responsiveness to cannabinoids. Comparison of CB1 cannabinoid receptor amino acid sequences between species substantiated evidence that the protein sequence is relatively well conserved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11324942     DOI: 10.1097/00041444-200010040-00004

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  3 in total

1.  Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents.

Authors:  Christian J Hopfer; Susan E Young; Shaun Purcell; Thomas J Crowley; Michael C Stallings; Robin P Corley; Soo Hyun Rhee; Andrew Smolen; Ken Krauter; John K Hewitt; Marissa A Ehringer
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-12-05       Impact factor: 3.568

Review 2.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

3.  Genetic variation and pharmacogenomics: concepts, facts, and challenges.

Authors:  Margret R Hoehe; Thomas Kroslak
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.